Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/4AB0 stock hub

FRA/4AB0 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/4AB0is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

302.5B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/4AB0

In the news

Latest news · FRA/4AB0

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5

P25 n/aP50 n/aP75 n/a

Trailing P/E97

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC22.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/4AB0 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

192

Groups with data

Currency

USD

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	57,000
Employees Change	5,000%
Employees Change Percent	10
Enterprise value	EUR 356.5B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 302.5B
Price	EUR 16.6
Price currency	EUR
Rev Per Employee	955,840.68x
Sic	2836
Symbol	fra/4AB0
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.03%
EV Earnings	114.35x
EV/EBIT	19.18x
EV/EBITDA	13.85x
EV/FCF	20.58x
EV/Sales	6.68x
FCF yield	5.73%
Forward P/E	13.5x
P/B ratio	-52.76x
P/E ratio	97.03x
P/S ratio	5.55x
PE Ratio10 Y	39.99x
PE Ratio3 Y	77.83x
PE Ratio5 Y	56.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.83%
EBITDA Margin	47.62%
FCF margin	31.81%
Gross margin	72.03%
Gross Profit	EUR 39.2B
Gross Profit Growth	11.06%
Gross Profit Growth Q	15.45%
Gross Profit Growth3 Y	3.97%
Gross Profit Growth5 Y	5.95%
Net Income	EUR 3.1B
Net Income Growth	-13.35%
Net Income Growth Q	-45.96%
Net Income Growth3 Y	-21.86%
Net Income Growth5 Y	-6.73%
Pretax Margin	9.51%
Profit Margin	5.79%
Profit Per Employee	EUR 54,701
ROA	10.03
Roa5y	8.68
ROCE	23.19
Roe5y	1,295.2
ROIC	22.24
Roic5y	22.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	5.32%
Cagr3y	8.95%
EPS Growth	-13.24
EPS Growth Q	-45.83
EPS Growth3 Y	-21.78
EPS Growth5 Y	-6.98
Revenue Growth	9.5x
Revenue Growth Q	12.43x
Revenue Growth3 Y	3.45x
Revenue Growth5 Y	4.59x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.46
Assets	EUR 118.4B
Cash	EUR 8.1B
Debt	EUR 63.2B
Debt EBITDA	EUR 2.41
Debt FCF	EUR 3.65
Equity	EUR -5.7B
Interest Coverage	7.52
Liabilities	EUR 124.1B
Net Cash	EUR -55.1B
Net Cash By Market Cap	EUR -18.21
Net Debt EBITDA	EUR 2.12
Net Debt FCF	EUR 3.18
Tangible Book Value	EUR -80.7B
Tangible Book Value Per Share	EUR -45.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.8
Inventory Turnover	3.67
Net Working Capital	EUR -8.3B
Quick ratio	0.52
Working Capital	EUR -7.4B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.04%
Dividend Growth	-4.45%
Dividend Growth Years	0%
Dividend per share	EUR 0.59
Dividend Years	4
Dividend Yield	3.53%
Ex Div Date	2026-04-15
Last Dividend	EUR 0.15
Payout Frequency	Quarterly
Payout Ratio	325.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	5.31%
200-day SMA	17.81
3Y total return	29.35%
50-day SMA	17.95
50-day SMA vs 200-day SMA	50over200
All Time High	22
All Time High Change	-24.55%
All Time High Date	2026-03-05
All Time Low	12.7
All Time Low Change	30.71%
All Time Low Date	2023-11-16
ATR	0.28
Ch YTD	-13.54
High	16.8
High52	22
High52 Date	2026-03-05
High52ch	-24.55%
Low	16.6
Low52	15.4
Low52 Date	2025-06-30
Low52ch	7.79%
Ma50ch	-7.5%
Price vs 200-day SMA	-6.79%
RSI	40.58
RSI Monthly	48.7
RSI Weekly	40.21
Sharpe ratio	0.04x
Sortino ratio	0.18
Total Return	3.48%
Tr YTD	-12.06
Tr1m	-1.48%
Tr1w	-2.92%
Tr3m	-6.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 19B
Operating Income Growth	15
Operating Income Growth Q	16.6
Operating Income Growth3 Y	0.7
Operating Income Growth5 Y	5.78
Operating margin	34.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,763,680,450%
Shares Insiders	0.07%
Shares Institutions	76.02%
Shares Qo Q	0%
Shares Yo Y	0.04%
Short Ratio	3.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 16.5B
Average Volume	0x
Bv Per Share	-3.27
CAPEX	EUR -1.1B
Ch1m	-2.35
Ch1w	-2.92
Ch1y	1.84
Ch3m	-7.78
Ch3y	15.68
Ch6m	-8.79
Change	-2.35%
Change From Open	-0.6
Close	17
Days Gap	-1.76
Depreciation Amortization	6,897,958,879.5
Earnings Date	2026-04-29
EBIT	EUR 19B
EBITDA	EUR 25.9B
EPS	EUR 1.76
F Score	7
FCF	EUR 17.3B
FCF EV Yield	4.86x
Financing CF	-9,147,413,100
Fiscal Year End	December
Founded	2,012
Income Tax	EUR 2B
Investing CF	-5,621,838,600
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	EUR 0.86
Lynch Upside	-94.85
Ma150	18.3
Ma150ch	-9.29%
Ma20	16.95
Ma20ch	-2.04%
Net CF	3,656,536,800
Open	16.7
P FCF Ratio	17.46
P OCF Ratio	16.44
Payment Date	2026-05-25
Position In Range	0
Price Date	2026-05-08
Price EBITDA	EUR 11.66
Relative Volume	2,000x
Revenue	54,482,918,700x
SBC By Revenue	1.57x
Share Based Comp	857,759,700
Tax By Revenue	3.72x
Tax Rate	39.06%
Tr6m	-7.23%
Z Score	2.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/4AB0 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.5%

$0.59 annual per share

Payout ratio

+325.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+3.5%

Next ex-dividend date: 2026-04-15

Performance

FRA/4AB0 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/4AB0?

Insider, institutional, and short-interest positioning.

Institutional ownership

+76.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/4AB0 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.6

Neutral momentum band

Price vs 200-day MA

-6.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/4AB0

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/4AB0 stock rating?

fra/4AB0 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/4AB0 analysis?

The full report lives at /stocks/fra/4AB0/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/4AB0?

The latest report frames fra/4AB0 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/4AB0 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.